Our round-up of biotech financings is led this week by Braveheart Bio, a San Francisco biotech that has launched with $185 million, a lead drug for hypertrophic cardiomyopathy (HCM), and Biogen CEO ...

Notre Dame might as well be Mel Gibson’s character in “Braveheart.” “Hold!” For the second consecutive week, the Fighting ...

Netflix viewers have rushed to watch a ‘terrifying’ crime drama based on a series of books by Stephen King. Released in 2017, ...

Netflix viewers have rushed to watch a ‘terrifying’ crime drama based on a series of books by Stephen King. Released in 2017, ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

The man accused of beating to death 87-year-old John Mackey in London has told his Old Bailey trial he “feels responsible” because he stole the Irishman’s bag from his hand. Peter Augustine (59), has ...

With $185 million in series A funding and an army of experienced leaders in its ranks, Braveheart Bio is setting off to joust with big names in an emerging heart disease drug arena. Backed by ...

Board to include Chris Viehbacher as Chair, with investor syndicate led by Andreessen Horowitz, Forbion, and OrbiMed with participation from Enavate Sciences (a platform of Patient Square Capital) and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It’s one of the largest ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

NEW YORK CITY – Curtis Sliwa says he’s charging into the final stretch of New York City’s mayoral race like "Braveheart" — confident, defiant and ready to die on his sword for the city he loves. In an ...